MBOT Microbot Medical Inc.
$1.03▲ +9.38%
Healthcare
Other
After hours
$1.07▲ +3.88%
Oct 27, 5:56 PM ET
Volume 1.11M
Avg Volume (10D) 609.0K
Key Metrics & Fundamentals
Market Cap
$69.18M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.93 - 2.86
% vs 50 MA
-18.94%
% vs 200 MA
-44.70%
RSI-14
40.3
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.73
Free Cash Flow
-$5.13M
Gross Rev
$241,000
Gross Profit
-$643,000
EBITDA
-$6.17M
COGS
$884,000
Operating Exp
$5.55M
Operating Income
-$6.19M
EBIT
-$6.19M
Pretax Income
-$5.63M
Net Income
-$5.63M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
GlobeNewswire · Oct 27, 2026 8:30 AM ET
Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.
GlobeNewswire · Oct 23, 2026 8:30 AM ET
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
GlobeNewswire · Oct 20, 2026 8:30 AM ET
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
GlobeNewswire · Oct 6, 2026 8:30 AM ET
Microbot Medical® Highlights Growth Strategy
GlobeNewswire · Sep 25, 2026 5:30 PM ET
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 11, 2026 10:25 AM ET
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
GlobeNewswire · Aug 11, 2026 9:20 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MBOT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.